dbACP: A Comprehensive Database of Anti-Cancer Peptides

6 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp07206 DHK GLLDLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.75 ±0.49 µM
dbacp07207 DHK GLLDLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.02 ± 0.12 µM
dbacp07208 DHK GLLDLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 20.45 ± 2.05 µM
dbacp07230 d-DHK GlldllhlllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 0.32 ± 0.07 µM
dbacp07231 d-DHK GlldllhlllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 0.23 ± 0.04 µM
dbacp07232 d-DHK GlldllhlllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 1.24 ± 0.03 µM